GlaxoSmithKline Pharmaceuticals Ltd reports Q2 FY27 consolidated net profit of ₹335.88 crore, up 30.4% year on year
- Consolidated revenue was ₹1,183.57 crore, up 20.8% year on year and 26.1% sequentially.
- No quarterly exceptional item was reported; auditors’ limited-review conclusions were unmodified.
- Appointed Sandeep Seth as Head – Ethics & Compliance, effective immediately.
- Approved Walker Chandiok & Co LLP as statutory auditors for FY28–FY32, subject to shareholder approval.